Enhanced insulin signaling via circulating ATG7: A potential therapeutic strategy for diabetes
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2503783123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Yi Guan und 26 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Translational Research Center, Shengjing Hospital, Health Sciences Institute, Key Laboratory of Medical Cell Biology, Ministry of Education,…. Hauptthemen laut MEDLINE: Signal Transduction, Insulin, Autophagy-Related Protein 7, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes and insulin resistance (IR) remain major global health challenges, underscoring the need for novel therapeutic strategies. Here, we identify an autophagy-independent role of circulating autophagy-related gene 7 (ATG7) in metabolic regulation. Circulating ATG7 enhances insulin sensitivity and glucose homeostasis by directly interacting with IRS1 and modulating insulin signaling (IS) through liver–muscle crosstalk. Mechanistically, ATG7 binds to IRS1, promoting its activation and the propagation of downstream IS. Notably, we identify an ATG7-derived peptide (Aap2) that recapitulates ATG7’s insulin-sensitizing effects and improves glycemic control in both Type 1 and Type 2 diabetic mouse models. These findings establish ATG7 as a key regulator of IS and suggest that targeting ATG7 may represent a promising therapeutic approach for IR and diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Translational Research Center, Shengjing Hospital, Health Sciences Institute, Key Laboratory of Medical Cell Biology, Ministry of Education, College of Basic Medical Science, Key Laboratory of Liaoning Province…
- Key Laboratory of Obesity and Glucose/Lipid Associated Metabolic Diseases, Health Sciences Institute, China Medical University, Shenyang, Liaoning Province 110122, China.
- Department of Medical Physiology, Graduate School of Medicine, Research Institute of Disaster Medicine, Chiba University, Chiba 260-0856, Japan.
- Research Institute of Disaster Medicine, Chiba University, Chiba 260-0856, Japan.
- Institut d'Investigació Biomèdica de Girona, University of Girona, Girona 17071, Spain.
- Key Laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang, Liaoning Province 110122, China.
ORCID-Profile: Yang Yu, Eunyoung Lee, Qiqiang Guo, Xiaoyou Jiang, Xiaoyu Song, Yanling Feng, Wan Yu, Difei Wang, Siru Hou, Jichun Tan, José-Manuel Fernández-Real, Antonio Vidal-Puig, Liu Cao
Zitieren
APA
Guan, Y., Yu, Y., Fu, M., Xu, H., Lee, E., Wang, H., Moreno-Navarrete, J. M., Deng, C., Li, Y., Song, K., Guo, Q., Jiang, X., Song, X., Guo, W., Feng, Y., Yi, F., Bai, N., Li, J., Chen, J., …, & Cao, L. (2026). Enhanced insulin signaling via circulating ATG7: A potential therapeutic strategy for diabetes. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2503783123
Vancouver
Guan Y, Yu Y, Fu M, Xu H, Lee E, Wang H, et al. Enhanced insulin signaling via circulating ATG7: A potential therapeutic strategy for diabetes. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2503783123
BibTeX
@article{Guan2026,
author = {Guan, Yi and Yu, Yang and Fu, Mengdi and Xu, Hongde and Lee, Eunyoung and Wang, Hanfeng and Moreno-Navarrete, José María and Deng, Chengsi and Li, Yuheng and Song, Kangjing and Guo, Qiqiang and Jiang, Xiaoyou and Song, Xiaoyu and Guo, Wendong and Feng, Yanling and Yi, Fei and Bai, Ning and Li, Jiabin and Chen, Jingyang and Shen, Wenjing and Yu, Wan and Wang, Difei and Hou, Siru and Tan, Jichun and Fernández-Real, José-Manuel and Vidal-Puig, Antonio and Cao, Liu},
title = {Enhanced insulin signaling via circulating ATG7: A potential therapeutic strategy for diabetes},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2503783123}
}
EUVIMED